lung cancer
Facts (9)
Sources
How to reduce inflammation in the body - MD Anderson Cancer Center mdanderson.org Mar 20, 2026 2 facts
claimPro-inflammatory diets are linked to higher risks of esophageal, oral, pharynx, breast, lung, colorectal, and stomach cancer.
claimChronic inflammation contributes to the initiation, progression, and spread of cancers, including colorectal, lung, stomach, esophageal, breast, and liver cancer, by damaging DNA, promoting cell proliferation, and creating an environment that favors tumor growth.
Chronic Inflammation - StatPearls - NCBI Bookshelf ncbi.nlm.nih.gov 1 fact
claimChronic low-level inflammation participates in the development of many cancer types, including kidney, prostate, ovarian, hepatocellular, pancreatic, colorectal, lung, and mesothelioma.
Acute v chronic inflammation in the body: what's the difference? cbhs.com.au Mar 20, 2020 1 fact
claimSmoking causes the immune system to overcompensate for toxins, causing white blood cells to attack rather than heal, which increases the risk of lung cancer.
Mitochondria and the dynamic control of stem cell homeostasis link.springer.com Apr 16, 2018 1 fact
referenceSayin et al. (2014) found that antioxidants accelerate lung cancer progression in mice.
Integrating allostasis and emerging technologies to study complex ... nature.com Nov 5, 2025 1 fact
referenceStabellini, N. et al. (2024) investigated the relationship between allostatic load/chronic stress and cardiovascular outcomes in patients diagnosed with breast, lung, or colorectal cancer, published in the Journal of the American Heart Association.
How does targeted therapy treat cancer? | UT MD Anderson mdanderson.org Jun 7, 2024 1 fact
claimResearch led by David Hong, M.D., and Ferdinandos Skoulidis, M.D., Ph.D., found that the drug sotorasib effectively treats lung cancer with the KRAS G12C mutation.
Positive and negative psychosocial impacts on cancer ... nature.com 1 fact
referenceA systematic review by Araújo, Simões, and Costa (2022) examined the influence of psychological factors on the risk of developing breast and lung cancer.
Phytochemical and Pharmacological Studies of Traditionally Used ... heraldopenaccess.us 1 fact
claimSilybin meglumine impedes epithelial to mesenchymal transition in lung cancer, according to Cufi et al. [100].